China introduced newest drug for control of chronic hepatitis B

Beijing. May 30. Silkroadnews - A new pharmaceutical drug for the treatment of hepatitis B was introduced in Beijing, People’s Daily reports.
The drug will open new opportunities for patients with hepatitis B and marks a breakthrough in China’s creation of advanced biotechnology, said Yang Xizhong, executive vice president of the Chinese Foundation for Hepatitis Prevention and Control.
According to Wang Guiqiang, director of the Department of Infectious Diseases at the First Hospital of Beijing University, the new medicine is a fantastic weapon for clinical doctors when it comes to immunotherapy.
It is hoped that more hepatopathy specialists will be able to support the experimental study of the drug in the fight against the hepatitis B virus.
Based on figures from 2015, the World Health Organization has already hit global targets to reduce new cases of viral hepatitis by 90 percent and is set to achieve 80 percent treatment coverage for chronic hepatitis B and C patients by 2030, the report reads.